[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase

Green Cross MS is showing strong performance.

As of 10:04 AM on the 16th, Green Cross MS is trading at 6,390 KRW on the KOSDAQ market, up 1,310 KRW (25.79%) from the previous trading day.

It is interpreted that the recent sharp increase in the number of patients hospitalized due to COVID-19 is influencing the stock price.

Green Cross MS was established in 2003 with the business purpose of manufacturing and selling in vitro diagnostic pharmaceuticals and medical devices, as well as manufacturing and selling pharmaceuticals and quasi-drugs.

The company is composed of three business divisions: diagnostic reagents, hemodialysis solutions, and diabetes. By handling products in various fields together, it supplies to a wide range of customers including public health centers, screening centers, internal medicine clinics, dermatology clinics, plastic surgery clinics, hospitals, general hospitals, and university hospitals, thereby maintaining an extensive domestic sales network.

This content was produced with the assistance of AI translation services.